SCHEMBL30061649

SCHEMBL30061649

Cc1sc2ccc([N+](=O)[O-])cc2c1Br

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.46
▸ MCL1 Q07820 2/20 0.46
▸ AHR P35869 1/20 0.46
▸ SAE1 Q9UBE0 1/20 0.46
▸ UBA2 Q9UBT2 1/20 0.46
▸ ALDH1A1 P00352 4/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ CYP3A4 P08684 2/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ HTT P42858 2/20 0.45
▸ TSHR P16473 2/20 0.44
▸ POLB P06746 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ NPY1R P25929 1/20 0.42
▸ NPY2R P49146 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ G6PD P11413 1/20 0.40
▸ TLR9 Q9NR96 1/20 0.40
▸ ACHE P22303 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23612353 1.00 MAPT (0.46) MAPTMCL1AHRSAE1UBA2
SCHEMBL11118149 0.79 SMN1; SMN2 (0.50) MAPTMCL1AHRSAE1UBA2
SCHEMBL13910134 0.74 ALDH1A1 (0.52) MAPTALDH1A1TDP1CYP3A4SMN1; SMN2
SCHEMBL13730638 0.73 SMN1; SMN2 (0.51) MAPTALDH1A1TDP1CYP3A4SMN1; SMN2
SCHEMBL11160019 0.73 MAPT (0.54) MAPTMCL1AHRSAE1UBA2
SCHEMBL15227310 0.73 MAPT (0.54) MAPTMCL1AHRSAE1UBA2
SCHEMBL3859690 0.73 MAPT (0.43) MAPTMCL1AHRSAE1UBA2
SCHEMBL13698355 0.73 EGFR (0.47) MAPTMCL1AHRSAE1UBA2
SCHEMBL26661128 0.72 ICAM1 (0.39) MAPTALDH1A1HTTPOLBLMNA
SCHEMBL30656235 0.72 ICAM1 (0.39) MAPTALDH1A1HTTPOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4085059-A1 HETEROARYL COMPOUNDS AS INHIBITORS OF PROGRAMMED NECROSIS PATHWAY, COMPOSITION AND METHOD USING THE SAME Accro Bioscience (HK) Limited (HK) 2022-11-09 — — EP disclosed
Send feedback